New Year's resolution from our President
3 January 2022
Hard to say what we expect for 2022, what we hope for is a lot easier. Would COVID really become endemic, a bad flu? Would we really be able to return to the “pre-corona normal”, see clients face to face, visit our colleagues all over the globe?
In any case, we will continue to do what we do best, serving our customers, both in the Life Sciences and in the Semiconductor business with top notch products and world class service. We buffered the issues in the supply chain to level playing field for our customers. We grew our capacity to enable our customers to benefit from the steep growth in demand and did so amid equipment and installation shortages, personnel absences and transportation problems. Sometimes, we are praised, we even get rewards, but most of the time, for our repeat business customers, we are like air: omnipresent and one less thing to worry about. For our prospects and customers in process development we strive to be the brother in arms, the colleague extra muros. Much of all the work to enable this is happening behind the scenes. It is a choice, it is who we are. Partners in business know that and they stay with us for the long haul. For 2022 we plan to again work and improve our service and our products even further. We have plans in place, we expect we can do it.
Being born in the year before the first IC was created (J.S. Kilby), I have seen the semiconductor business grow from a pretty dangerous, small scale activity into the realm of the most sophisticated technology in the world that it is today. Professionalization and specialization increased at light speed.
New challenges lie ahead, becoming greener and more sustainable not the least of these, a boundary condition asking for even more creativity. At JSR as well as at our customers new generations of people are working on it. The law of Moore and more than Moore, the ever present drive towards further miniaturization and increased complexity, both are alive and kicking, and who knows, some disruptive new development may lay on the horizon. Personally, I have worked my last full year for JSR, I will retire in December, after that I will follow the developments from the sidelines and explain to my grandchildren how we created the first GaAs transistor in Ghent on the evening before Christmas eve of the year that I married their grandma, provided they would be interested.
Share with friends:
17 September 2024
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification
JSR Life Sciences, a JSR Group company, today announced the launch of its next generation protein A chromatography resin, Amsphere™ A+.
16 May 2024
JSR to make Yamanaka Hutech, a manufacturer of high-purity chemicals for semiconductors, a wholly owned subsidiary
30 November 2023
New Energy Collaborative Aims to Accelerate Creation of Low-Carbon Energy Access in Asia-Pacific for the Semiconductor Climate Consortium
2 November 2022
JSR Joins Semiconductor Climate Consortium as Founding Member
JSR Corporation today announced it has become a founding member of the new Semiconductor Climate Consortium (SCC), a group formed with other companies from across the semiconductor value chain and SEMI, the global industry association representing the electronics manufacturing and design supply chain.
13 October 2022
JSR Electronic Materials Korea to be a JSR Wholly Owned Subsidiary
SR Corporation (Representative Director, CEO: Eric Johnson, “JSR”) announced today that it has signed a Share Purchase Agreement to acquire the 60% of shares held by PERI Corporation (“PERI”) and make JSR Electronic Materials Korea Co., Ltd. ("JEMK") a wholly owned subsidiary of JSR. JEMK is a joint venture between PERI and JSR, which is the sales agent/distributor of its Electronic Materials business in Korea.
15 March 2022
JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy
11 October 2021
